You are here

breast cancer

Approved Pfizer breast cancer drug impresses in latest study

Yahoo/Reuters

Wed, 04/15/15 - 02:35 pm

Breast cancer drug, key to Nektar growth plans, fails clinical trial

Bizjournals.com

Tue, 03/17/15 - 07:23 pm

Can Pfizer's new breast cancer med really cruise to $4B and beyond?

Fierce Pharma Marketing

Tue, 02/24/15 - 07:00 pm

Pfizer breast cancer drug gets early FDA approval

Yahoo/AP

Wed, 02/4/15 - 09:07 am

HER-2 postive breast cancer

Breast Cancer Tests Betray "Precision Medicine" Branding

Forbes

Tue, 02/3/15 - 09:09 am

Precision Medicine Initiative

personalized medicine

Pfizer nears a new dawn in oncology with AstraZeneca in the rearview

Fierce Biotech

Fri, 01/9/15 - 08:37 am

Drug Data Dump: Pfizer, Biogen, AbbVie

Forbes

Thu, 01/8/15 - 02:46 pm

Pfizer, FDA in talks on prescription details for key breast cancer drug

Yahoo/Reuters

Thu, 01/8/15 - 11:42 am

FDA staff recommends Novartis copy of Amgen's Neupogen

Yahoo/Reuters

Mon, 01/5/15 - 09:29 am

chemotheraphy-induced neutropenia

Double blow for Roche as breast cancer, Alzheimer's studies fail

Yahoo/Reuters

Fri, 12/19/14 - 08:29 am

Alzheimer's disease

Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer

Seeking Alpha

Wed, 12/17/14 - 08:53 am

triple negative breast cancer

Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer

Yahoo/MarketWired

Sat, 12/13/14 - 11:26 am

Cianna Medical wins FDA nod for breast surgery device

Mass Device

Fri, 12/12/14 - 10:32 am

Puma Biotech Drops as Breast Cancer Drug Filing Delayed

Bloomberg

Tue, 12/2/14 - 07:28 pm

Puma Biotechnology

Puma Biotech says cancer drug fails mid-stage study

Yahoo/Reuters

Thu, 11/13/14 - 07:16 pm

Puma Biotechnology

Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy

Yahoo

Tue, 10/28/14 - 10:28 am

Bristol-Myers Squibb

Roche, Merck extend immunotherapy fight to breast cancer

Yahoo/Reuters

Fri, 10/17/14 - 10:08 am

Roche's Perjeta increases survival in late-stage breast cancer study

First Word Pharma

Mon, 09/29/14 - 08:53 am

TapImmune Releases Interim Data on Phase 1 Cancer Trial

Drug Discovery and Development

Wed, 09/17/14 - 08:42 am

Why Clovis Oncology Was Up 10% In After-Hours Trading Yesterday

Bidness Etc.

Thu, 09/11/14 - 08:20 am

Clovis Oncology

Pages